Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Higuchi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Modern Rheumatology|November 9, 2021
Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohortTomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|August 3, 2022
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohortNaoki Sugimoto, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|February 14, 2023
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohortNaohiro Sugitani, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|December 17, 2021
Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohortEri Sugano, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|February 4, 2021
Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settingsMoeko Ochiai, Eiichi Tanaka, Eri Sato, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Modern Rheumatology|November 9, 2021
Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohortTomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|August 3, 2022
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohortNaoki Sugimoto, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|February 14, 2023
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohortNaohiro Sugitani, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|December 17, 2021
Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohortEri Sugano, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|February 4, 2021
Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settingsMoeko Ochiai, Eiichi Tanaka, Eri Sato, et al.
Pageof 2